Invention Grant
- Patent Title: Bicyclic heterocycles as FGFR inhibitors
-
Application No.: US16923799Application Date: 2020-07-08
-
Publication No.: US11591329B2Publication Date: 2023-02-28
- Inventor: Oleg Vechorkin , Chao Qi , Minh Nguyen , Anlai Wang , Wenqing Yao
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; A61K45/06
Abstract:
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR3 enzyme and are useful in the treatment of FGFR3-associated diseases such as cancer.
Public/Granted literature
- US20210009582A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Public/Granted day:2021-01-14
Information query
